Nanowear Heart Failure Management Multi-sensor Algorithm

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

August 21, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Heart Failure
Interventions
DEVICE

SimpleSENSE

The Nanosense study is observational only. No interventions will be triggered by the SimpleSense device

Trial Locations (1)

17033

RECRUITING

Penn State Health Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
collaborator

Milton S. Hershey Medical Center

OTHER

collaborator

Hackensack Meridian Health

OTHER

lead

Nanowear Inc.

INDUSTRY